About ipratropium bromide
Short-acting anticholinergic bronchodilator
Used for
- Relieves wheezing and breathlessness in chronic obstructive pulmonary disease (COPD).
- Sometimes used with other medicines for acute asthma symptoms.
Usual adult dose
For COPD, commonly 500 micrograms by nebulizer three or four times daily; dosing varies by condition and local guidance.
Usual dose in children
For asthma, commonly 250–500 micrograms by nebulizer, repeated as directed; pediatric dosing depends on age and clinical setting.
Common side effects
- Dry mouth or throat irritation
- Cough or headache
- Blurred vision if mist enters the eyes
- Palpitations or difficulty passing urine
Important warnings
- Avoid getting nebulized mist in the eyes; it may cause eye pain or blurred vision.
- Seek urgent care for sudden worsening breathing after a dose.
- Use caution with narrow-angle glaucoma or difficulty urinating.
- This medicine does not replace emergency treatment for severe breathing difficulty.
Pregnancy
Use when needed after weighing benefits and risks; human pregnancy information is limited.
Breastfeeding
Transfer into milk is expected to be low; use when clinically needed.
Interactions
- Other anticholinergic medicines may increase side effects.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.